KALA PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.

At the 2022 Annual Meeting of Stockholders of Kala Pharmaceuticals, Inc. (the "Company") held on June 16, 2022, the Company's stockholders voted on the following proposals:

The Company's stockholders elected Mr. Mark Iwicki and Dr. Mark S. Blumenkranz

as Class II directors, each to serve for a three-year term expiring at the

1. 2025 Annual Meeting of Stockholders and until his successor has been duly

    elected and qualified. The results of the stockholders' vote with respect to
    the election of such Class II directors were as follows:


                                                    Broker
                                       Votes         Non-
                       Votes For     Withheld       Votes
Mark Iwicki            30,738,402    2,509,262    13,897,318
Mark S. Blumenkranz    31,930,406    1,317,258    13,897,318

The Company's stockholders ratified the appointment of Deloitte & Touche LLP

2. as the Company's independent registered public accounting firm for the fiscal

    year ending December 31, 2022. The results of the stockholders' vote with
    respect to such ratification were as follows:


                                                   Broker Non-

Votes For Votes Against Votes Abstaining Votes 46,707,694 294,888

           142,400              0

© Edgar Online, source Glimpses